PLRX
Pliant Therapeutics Inc

1,674
Loading...
Loading...
Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
171

Frequently Asked Questions

What is Market Cap of Pliant Therapeutics Inc?
What is the 52-week high for Pliant Therapeutics Inc?
What is the 52-week low for Pliant Therapeutics Inc?
What is Pliant Therapeutics Inc stock price today?
What was Pliant Therapeutics Inc stock price yesterday?
What is the PE ratio of Pliant Therapeutics Inc?
What is the Price-to-Book ratio of Pliant Therapeutics Inc?
What is the 50-day moving average of Pliant Therapeutics Inc?
How many employess does Pliant Therapeutics Inc has?

Latest PLRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.